Dr Bill Haynes
Bill Haynes is Corporate Vice President of the Novo Nordisk Research Centre Oxford and Visiting Professor in Metabolic Medicine at the University of Oxford. Bill has been a member of REACT's Independent Strategic Advisory Board since …
Using lipid nanoparticles to deliver small RNAs to the heart
One of the bottlenecks for any application involving nucleic acid administration to the heart is efficiency of cardiac delivery. In the cases of both coding mRNA or RNA interference therapeutics (miRNAs, siRNAs), delivery needs to be facilitated in order …
Dr Ermes Carulli
Ermes is a cardiologist and biotechnologist with a special interest in interventional cardiology and advanced cardiac imaging. Ermes has a PhD in Translational Medicine and experience in early clinical trial design and delivery, having previously led a …
Dr Manendra Pachauri
Manendra's expertise lies in the bioengineering of lipid nanoparticles (LNPs) for the delivery of therapeutic non-coding RNAs (ncRNA) to cardiomyocytes. Currently, the inability to achieve efficient in vivo cardiac targeting remains a critical bottleneck …
Dr Camilla Olianti
Camilla is an MSCA Postdoctoral Fellow in Mauro Giacca’s research group at King’s College London. Within REACT, Camilla's role is to investigate the structural features of cardiac regeneration in 3D at high resolution. Camilla uses advanced optical …
Dr Jacinta Kalisch-Smith
Jacinta is a BHF Intermediate Basic Science Fellow at the University of Edinburgh …
Dr Thomas Mulroney
Thomas Mulroney is a BHF Immediate Basic Science Research Fellow at the University of Oxford. …
Dr Francesca Bortolotti
Francesca is a research associate at King's College London. …
Professor Nicola Smart
Nicola is Professor of Cardiovascular Science at the University of Oxford. …
Claire Kavanagh
Claire is a REACT-funded research assistant at the University of Oxford. …